Coya Therapeutics, Inc.'s Quiet Period Set To Expire on February 7th (NASDAQ:COYA)
Coya Therapeutics, Inc.'s Quiet Period Set To Expire on February 7th (NASDAQ:COYA)
Coya Therapeutics' (NASDAQ:COYA – Get Rating) quiet period is set to expire on Tuesday, February 7th. Coya Therapeutics had issued 3,050,000 shares in its IPO on December 29th. The total size of the offering was $15,250,000 based on an initial share price of $5.00. During Coya Therapeutics' quiet period, insiders and any underwriters involved in the IPO are prevented from issuing any research reports or earnings estimates for the company because of regulations issued by the Securities and Exchange Commission. Following the end of the company's quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.
Coya Therapeutics（纳斯达克股票代码：COYA — Get Rating）的静默期定于2月7日星期二到期。Coya Therapeutics在12月29日的首次公开募股中发行了305万股股票。按5.00美元的初始股价计算，此次发行的总规模为15250,000美元。在Coya Therapeutics的平静期，由于美国证券交易委员会发布的法规，内部人士和任何参与首次公开募股的承销商都无法发布公司的任何研究报告或收益估算。在公司的平静期结束后，担任承销商的经纪公司很可能会开始对该公司进行研究报道。
Analysts Set New Price Targets
分析师设定了新的价格目标
Separately, Chardan Capital initiated coverage on Coya Therapeutics in a report on Thursday, January 26th. They set a "buy" rating and a $9.00 price target for the company.
另外，Chardan Capital在1月26日星期四的一份报告中开始对Coya Therapeutics进行报道。他们为该公司设定了 “买入” 评级和9.00美元的目标价格。
Coya Therapeutics Price Performance
Coya Therapeutics 价格
Shares of COYA stock opened at $3.95 on Tuesday. Coya Therapeutics has a 12 month low of $3.68 and a 12 month high of $5.67.
COYA股票周二开盘价为3.95美元。Coya Therapeutics创下12个月低点3.68美元，12个月高点为5.67美元。
About Coya Therapeutics
关于 Coya Therapeut
Coya Therapeutics Inc is a clinical-stage biotechnology company. It involved in developing proprietary treatments focused on the biology and potential therapeutic advantages of regulatory T cells to target systemic inflammation and neuroinflammation. The company's therapeutic platforms include Treg-enhancing biologics, Treg-derived exosomes, and autologous Treg cell therapy.
Coya Therapeutics Inc是一家处于临床阶段的生物技术公司。它参与开发专有疗法，侧重于调节性T细胞的生物学和潜在治疗优势，以靶向全身性炎症和神经炎症。该公司的治疗平台包括增强调节性TREG的生物制剂、TREG衍生的外泌体和自体调节性Treg细胞疗法。
Featured Stories
精选故事
- Get a free copy of the StockNews.com research report on Coya Therapeutics (COYA)
- Energizer Holdings Inc; Losing Power Or Electrifying Time To Buy?
- Can Cummins Power To A New High?
- How to Find Penny Stocks to Invest and Trade
- ONSemi Is Marching Higher On Great Results
- What Tyson Foods Q1 Means For Staples Stocks
- 免费获取 StockNews.com 关于 Coya Therapeutics (COYA) 的研究报告
- Energizer Holdings Inc；失去电力还是在浪费购买时间？
- 康明斯能否再创新高？
- 如何寻找细价股进行投资和交易
- OnSemi 凭借出色的成绩向前迈进
- 泰森食品第一季度对斯台普斯股票意味着什么
Receive News & Ratings for Coya Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coya Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
接收 Coya Therapeutics 每日的新闻和评级 -在下面输入您的电子邮件地址，即可通过Marketbeat.com的免费每日电子邮件时事通讯接收Coya Therapeutics及相关公司的最新新闻和分析师评级的简明每日摘要。
译文内容由第三方软件翻译。